Inflammatory changes of the sigmoid-derived neovagina were observed in the most patients. Clinically, these changes appear similar to those encountered in diversion colitis.
All the papers from the March 2016 issue of Fertility and Sterility.
Our data provide evidence that rapamycin (mTOR), particularly mTORC1, controls the glycolytic and oxidative profiles of human Sertoli cells. The mTOR signaling may be a pharmacologic target to control male reproductive potential.
C Jun NH2 terminal Kinase JNK inhibitor Bentamapimod reduces induced endometriosis in baboons: an assessor blind placebo controlled randomized study
We discuss how c-Jun NH2-terminal kinase inhibition reduces endometriosis without hormonal suppression.
Artificial oocyte activation with calcium ionophore does not cause a widespread increase in chromosome segregation errors in the second meiotic division of the oocyte
Artificial oocyte activation with calcium ionophore does not cause a widespread increase in chromosome segregation errors in the second meiotic division. However, we recommend that it is applied selectively to patients with specific indications.
Effect of two assisted oocyte activation protocols used to overcome fertilization failure on the activation potential and calcium releasing pattern
The assisted oocyte activation protocol with the use of ionomycin is more efficient than the use of A23187 in both mouse and human oocytes.
The authors identify PCOS as an independent risk factor for the development of specific pregnancy complications in singleton pregnancies after IVF with or without intracytoplasmic sperm injection.
Cross border reproductive care in North America: a pilot study testing a prospective data collection program for IVF clinics in Canada and the United States
Nonidentifying summary data on cross-border reproductive care were considered important by responding Canadian Fertility and Andrology Society and Society for Assisted Reproductive Technology members. However, only one center from these societies was willing to collect and submit data.
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
These findings suggest that treatment for infertility does not significantly increase the risk of ovarian cancer among women with a BRCA mutation.
The PROMISe trial: a pilot randomized placebo controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids
A placebo effect may explain some of the improvement in fibroid symptoms after magnetic resonance-guided focused ultrasound among women with uterine fibroids.
Cancer survivors commonly experience amenorrhea, especially those who receive chemotherapy, are nulligravida, or are older at diagnosis. Most women resume menses within 2 years of diagnosis or not at all.
A discussion of how oocyte vitrification is clinically efficient for elective fertility preservation in the largest series reported to date and how the demand for this option is increasing.
Ethnicity or environment? Effects of migration on ovarian reserve among Bangladeshi women in the United Kingdom
Differences in ovarian reserve between age-matched Bangladeshis who moved to London as children or adults highlight the influence of developmental environments rather than ethnicity on the tempo of reproductive aging.
Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study
Systematic change from norethindrone acetate to dienogest as first-choice progestin for endometriosis was associated with enhanced drug tolerability and similar improvement in pain relief, quality of life, and patient satisfaction.
Monochorionic diamniotic in vitro fertilization twins have a decreased incidence of twin to twin transfusion syndrome
The incidence of twin-to-twin transfusion syndrome is lower in in vitro fertilization versus spontaneously conceived monochorionic diamniotic twin pregnancies.
The magnitudes of risk for early pregnancy loss after in vitro fertilization for all infertility diagnoses were small. The risks were similar when transferring similar quality embryos in fresh or frozen cycles.
Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic
Among a prospective cohort of women undergoing in vitro fertilization treatments at an academic fertility center, urinary methylparaben, propylparaben, and butylparaben concentrations were not associated with clinical in vitro fertilization outcomes.
Blastocyst development in single medium with or without renewal on day 3: a prospective cohort study on sibling donor oocytes in a time lapse incubator
Under a carefully controlled environment, human embryos can be cultured in a single medium up to the blastocyst stage with no need to renew the medium on day 3.
We discuss the different policies of centers regarding obesity and access to assisted reproductive technology.
Does the addition of growth hormone to the in vitro fertilization intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized controlled trial
The addition of growth hormone to the antagonist protocol in poor-responder women undergoing in vitro fertilization/intracytoplasmic sperm injection cycles resulted in better cycle outcomes but did not significantly affect pregnancy rates.
Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation
We discuss how short-term pituitary suppression decreases antral follicle count.